170 related articles for article (PubMed ID: 3338193)
1. Quantitation and IgG subclass distribution of antichromatin autoantibodies in SLE mice.
Fisher CL; Eisenberg RA; Cohen PL
Clin Immunol Immunopathol; 1988 Feb; 46(2):205-13. PubMed ID: 3338193
[TBL] [Abstract][Full Text] [Related]
2. IgG1 and IgG2a production by autoimmune B cells treated in vitro with IL-4 and IFN-gamma.
Klinman DM
J Immunol; 1990 Apr; 144(7):2529-34. PubMed ID: 2108205
[TBL] [Abstract][Full Text] [Related]
3. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
[TBL] [Abstract][Full Text] [Related]
4. Association between anti-Sm and anti-ribosomal P protein autoantibodies in human systemic lupus erythematosus and MRL/lpr mice.
Elkon KB; Bonfa E; Llovet R; Eisenberg RA
J Immunol; 1989 Sep; 143(5):1549-54. PubMed ID: 2760462
[TBL] [Abstract][Full Text] [Related]
5. B cell genotype determines the fine specificity of autoantibody in lpr mice.
Kakkanaiah VN; Sobel ES; MacDonald GC; Cheek RL; Cohen PL; Eisenberg RA
J Immunol; 1997 Jul; 159(2):1027-35. PubMed ID: 9218626
[TBL] [Abstract][Full Text] [Related]
6. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen.
Burlingame RW; Rubin RL; Balderas RS; Theofilopoulos AN
J Clin Invest; 1993 Apr; 91(4):1687-96. PubMed ID: 8473512
[TBL] [Abstract][Full Text] [Related]
7. MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus.
Treadwell EL; Cohen P; Williams D; O'Brien K; Volkman A; Eisenberg R
J Immunol; 1993 Jan; 150(2):695-9. PubMed ID: 8419494
[TBL] [Abstract][Full Text] [Related]
8. Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.
Steiman AJ; Urowitz MB; Ibañez D; Li TT; Gladman DD; Wither J
J Rheumatol; 2015 May; 42(5):810-6. PubMed ID: 25729033
[TBL] [Abstract][Full Text] [Related]
9. Isotype progression and clonality of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice.
Eisenberg RA; Craven SY; Cohen PL
J Immunol; 1987 Aug; 139(3):728-33. PubMed ID: 3474277
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal IgM rheumatoid factors derived from arthritic MRL/Mp-lpr/lpr mice.
Theofilopoulos AN; Balderas RS; Hang L; Dixon FJ
J Exp Med; 1983 Sep; 158(3):901-19. PubMed ID: 6224885
[TBL] [Abstract][Full Text] [Related]
11. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice.
Monneaux F; Dumortier H; Steiner G; Briand JP; Muller S
Int Immunol; 2001 Sep; 13(9):1155-63. PubMed ID: 11526096
[TBL] [Abstract][Full Text] [Related]
12. IgG anti-cardiolipin antibodies in murine lupus.
Gharavi AE; Mellors RC; Elkon KB
Clin Exp Immunol; 1989 Nov; 78(2):233-8. PubMed ID: 12412755
[TBL] [Abstract][Full Text] [Related]
13. Specificity and molecular characteristics of monoclonal IgM rheumatoid factors from arthritic and non-arthritic mice.
Aguado MT; Balderas RS; Rubin RL; Duchosal MA; Kofler R; Birshtein BK; Secher DS; Dixon FJ; Theofilopoulos AN
J Immunol; 1987 Aug; 139(4):1080-7. PubMed ID: 2440945
[TBL] [Abstract][Full Text] [Related]
14. Natural antibodies that react with V-region peptide epitopes of DNA-binding antibodies are made by mice with systemic lupus erythematosus as disease develops.
Ward FJ; Knies JE; Cunningham C; Harris WJ; Staines NA
Immunology; 1997 Nov; 92(3):354-61. PubMed ID: 9486108
[TBL] [Abstract][Full Text] [Related]
15. B cell dependence on and response to accessory signals in murine lupus strains.
Prud'homme GJ; Balderas RS; Dixon FJ; Theofilopoulos AN
J Exp Med; 1983 Jun; 157(6):1815-27. PubMed ID: 6406639
[TBL] [Abstract][Full Text] [Related]
16. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
Front Immunol; 2020; 11():1047. PubMed ID: 32625200
[TBL] [Abstract][Full Text] [Related]
17. Mononuclear phagocyte system dysfunction in murine SLE: abnormal clearance kinetics precede clinical disease.
Meryhew NL; Shaver C; Messner RP; Runquist OA
J Lab Clin Med; 1991 Mar; 117(3):181-93. PubMed ID: 2002275
[TBL] [Abstract][Full Text] [Related]
18. Macrophage I-A/I-E expression and macrophage-stimulating lymphokines in murine lupus.
Kofler R; Schreiber RD; Dixon FJ; Theofilopoulos AN
Cell Immunol; 1984 Aug; 87(1):92-100. PubMed ID: 6204780
[TBL] [Abstract][Full Text] [Related]
19. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
Merino R; Iwamoto M; Fossati L; Izui S
J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
[TBL] [Abstract][Full Text] [Related]
20. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis.
Takahashi S; Nose M; Sasaki J; Yamamoto T; Kyogoku M
J Immunol; 1991 Jul; 147(2):515-9. PubMed ID: 2071894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
